006620 — DongKoo Bio & Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Market Cap
KR₩146bn
Enterprise Value
KR₩228bn
Revenue
KR₩249bn

Annual balance sheet for DongKoo Bio & Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,507	31,956	34,785	21,457	36,244
Net Total Accounts Receivable
Net Total Receivables	17,592	16,408	19,403	22,449	23,953
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	72,353	73,832	87,417	88,365	107,242
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	40,377	40,051	39,681	50,483	66,222
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	144,353	154,786	172,059	191,103	244,061
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40,508	50,022	66,044	73,318	115,251
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	49,701	54,662	69,953	80,703	138,729
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	94,653	100,124	102,106	110,400	105,332
Total Liabilities & Shareholders' Equity	144,353	154,786	172,059	191,103	244,061
Total Common Shares Outstanding